Afuresertib HCl
编号: 161227116
Cas号: 1047645-82-8
纯度: 98%
Afuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor GSK2110183 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Afuresertib HCl |
|---|---|
| Iupac 化学名称 | Afuresertib HCl |
| 同义词 | GSK2110183; GSK 2110183; GSK-2110183; GSK2110183B; GSK 2110183B; GSK2110183B; Afuresertib |
| 英文同义词 | GSK2110183; GSK 2110183; GSK-2110183; GSK2110183B; GSK 2110183B; GSK2110183B; Afuresertib |
| 分子式 | C18H18Cl3FN4OS |
| 分子量 | 463.78 |
| InChiKey | |
| InChi | |
| Cas号 | 1047645-82-8 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
